Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weiss

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Blood|August 27, 2011
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosingDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|April 30, 2026
Ethical considerations for using alternative methods of consent in neonatal clinical trials: recommendations from a modified Delphi consensus processElliott Mark Weiss, Abigail Brickler, Abril Beretta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2014
Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantationJackrapong Bruminhent, Zi-Xuan Wang, Carol Hu, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Leukemia & Lymphoma|November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell TransplantationSameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemiaChris L Pashos, Christopher R Flowers, Neil E Kay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
JAMA Network Open|January 12, 2021
Parental Factors Associated With the Decision to Participate in a Neonatal Clinical TrialElliott Mark Weiss, Aleksandra E Olszewski, Katherine F Guttmann, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Blood|August 27, 2011
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosingDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|April 30, 2026
Ethical considerations for using alternative methods of consent in neonatal clinical trials: recommendations from a modified Delphi consensus processElliott Mark Weiss, Abigail Brickler, Abril Beretta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 6, 2014
Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantationJackrapong Bruminhent, Zi-Xuan Wang, Carol Hu, et al.
Blood|April 20, 2010
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemiaPeter G Maslak, Tao Dao, Lee M Krug, et al.
Leukemia & Lymphoma|November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell TransplantationSameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Investigational New Drugs|April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibitionMargaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemiaChris L Pashos, Christopher R Flowers, Neil E Kay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
JAMA Network Open|January 12, 2021
Parental Factors Associated With the Decision to Participate in a Neonatal Clinical TrialElliott Mark Weiss, Aleksandra E Olszewski, Katherine F Guttmann, et al.
Pageof 6